We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Alcon teams with AstraZeneca, NovaBay.
- Abstract
This article reports on the collaborative research agreement signed by Alcon with AstraZeneca for exclusive ophthalmic discovery and potential development rights to AstraZeneca's compound library. The partnership aims to develop drugs that will treat sight-threatening conditions such as glaucoma and retinal diseases. Meanwhile, Alcon and its partner NovaBay Pharmaceuticals Inc. has started treating patients in a clinical trial of an antimicrobial compound for viral conjunctivitis.
- Subjects
RESEARCH &; development partnership; ALCON Laboratories Inc.; ASTRAZENECA PLC; DRUG development; EYE diseases; CLINICAL trials; NOVABAY Pharmaceuticals Inc.
- Publication
Optometry Times, 2009, Vol 1, Issue 6, p14
- ISSN
0890-7080
- Publication type
Article